Latest Breaking News On - Head of ophthalmology research at glaxosmithkline - Page 1 : comparemela.com

/PRNewswire/ Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing novel oral therapies for retinal vascular diseases within.

Gabriela burianPeter adamsonUlrik mouritzenDanish innovation foundation innovationsfondenNovo holdingsDanish growth foundationHead of ophthalmology research at glaxosmithklineBioinnovation instituteChief scientificTherapeutics apsChief scientific officerVice presidentOphthalmology researchLead biologistTenpoint therapeuticsDiabetic retinopathy